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Key points: 
• ATMIN deletion using Vav-Cre causes chronic leukopenia, with fewer B 
cells and common myeloid progenitors 
• Long-term hematopoietic stem cells in ATMIN-deficient mice show 
increased cell cycling and are more prone to exhaustion under stress 
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Abstract 
The ATM-interacting protein ATMIN mediates non-canonical ATM signaling in 
response to oxidative and replicative stress conditions. Like ATM, ATMIN can 
function as a tumor suppressor in the hematopoietic system: deletion of Atmin 
under the control of CD19-Cre results in B cell lymphomas in aging mice. ATM 
signaling is essential for lymphopoiesis and hematopoietic stem cell (HSC) 
function; however, little is known about the role of ATMIN in hematopoiesis. 
We thus sought to investigate if the absence of ATMIN would affect primitive 
hematopoietic cells in an ATM-dependent or -independent manner. Apart from 
its role in B cell development, we show that ATMIN has an ATM-independent 
function in the common myeloid progenitors (CMPs) by deletion of Atmin in the 
entire hematopoietic system using Vav-Cre. Despite the lack of lymphoma 
formation, ATMIN-deficient mice developed chronic leukopenia as a result of 
high levels of apoptosis in B cells and CMPs and induced a compensatory 
mechanism in which HSCs displayed enhanced cycling. Consequently, 
ATMIN-deficient HSCs showed impaired regeneration ability, with the 
induction of the DNA oxidative stress response, especially when aged. ATMIN 
therefore has multiple roles in different cell types and its absence results in 
perturbed hematopoiesis, especially during stress conditions and aging. 
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Introduction  
 ATM (ataxia telangiectasia mutated) coordinates cell-cycle checkpoints 
with DNA repair in response to DNA damage1. ATM can be activated by the 
MRN complex (MRE11/RAD50/NBS1) via interaction with NBS12 but can also 
be activated by the ATM interactor ATMIN3, also known as ASCIZ (McNees at 
al, 2005 EMBO J). ATMIN has a complementary function to NBS1: NBS1 is 
required for ionizing radiation-induced ATM signaling, whereas ATMIN is 
required for ATM activation following hypotonic or replication stress3-5. 
 ATMIN has been shown to function in conditions of oxidative stress 
and aging6 and also as a transcription factor7. We have previously shown that 
ATMIN-deleted B cells (induced by CD19-Cre) have impaired class switch 
recombination and increased genomic instability, leading to B cell 
lymphomas8. In contrast, mice conditionally deleted of Atmin using Mx1-Cre 
developed B cell lymphopenia9. It is unclear whether the lack of B cell 
lymphoma formation in this mouse model is due to a B cell developmental 
defect or to other deficiencies in primitive hematopoietic cells that prevent the 
accumulation of genetically unstable cells. Since the role of ATMIN in 
hematopoietic stem/progenitor cells is currently unknown, we sought to 
investigate a possible role for ATMIN in primitive hematopoietic cells and 
whether this would be ATM-dependent or -independent.  
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Materials and Methods 
Vav-Atmin
Δ/Δ mice 
Atminf/f mice (described previously6,8) were crossed with heterozygous Vav-
Cre mice to generate Vav-Atmin∆/∆ mice. Gene deletion efficiency and 
genotyping was determined by PCR using primers specific for the floxed exon 
4, deleted exon 4, WT Atmin alleles and for Vav-Cre and immunoblotting 
(Figures S1A and S1B and Table S1). 
 
Intracellular immunostaining 
 Briefly10, cells were incubated with antibodies against extracellular 
antigens then fixed in PBS with 2% methanol-free formaldehyde at room 
temperature (RT) (for Ki-67, BD Biosciences) or at 37°C (for pS824-Kap1, 
Bethyl Laboratories; Bim, Cell Signaling; pS139-γH2AX, Abcam) for 10 min. 
Cells were permeabilized with PBS containing 0.1% Triton-X-100 (Sigma) for 
10 min at RT, blocked using PBS containing 5% serum for 15 min and 
incubated with primary antibodies at 4°C for 1 hour, followed by appropriate 
secondary antibodies in the same conditions. Cells were resuspended with 
PBS/2% FBS containing DAPI and pulse processing was used to exclude any 
unstained, apoptotic and clumped cells. 
 
Please see Supplementary Information for more detailed Methods. 
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Results and discussion 
 Vav-Atmin∆/∆ mice were born healthy and were not anemic but were 
leukopenic at 8-12 weeks (Figure S1C-D). Unlike the CD19-Cre model8, mice 
did not develop lymphoma even in aged mice, and instead numbers of splenic 
B cells were reduced (Figure S2A-B) which resulted in a complete absence of 
germinal centers (GC) (Figure S2C). B cell apoptosis was increased, and 
while ROS levels were unaffected there was a pronounced reduction in Dynll1 
expression, as previously described9 (Figure S2D-F). Additionally, ATMIN-
deficient B cells displayed a significant increase in the DNA damage signaling, 
consistent with an ATM-dependent competitive function of ATMIN3,4 (Figure 
S2G-H). Numbers of pre-B cells in the bone marrow (BM) were also 
significantly lower (Figure S2I-K). These data suggest an early developmental 
defect with a concomitant high level of apoptosis that does not allow the 
accumulation of damaged B cells in the Mx-Cre model9 and the Vav-Atmin∆/∆ 
mice. We then analyzed the primitive hematopoietic cell compartment in more 
detail.  
 In young ATMIN-deficient mice (8-12 weeks), a ~40% reduction in BM 
cellularity was observed across all cell types, with a prominent reduction in the 
frequency of common myeloid progenitors (CMPs) (Figure S3A-B). The very 
modest oxidative stress detected in the CMPs did not seem to play an evident 
role in reducing this cellular fraction in ATMIN-deficient mice (Figure 1A-C). 
We observed neither an increased DNA damage response (Figure 1D-E) nor 
evidence of developmental defects (Figure 1F) in Vav-Atmin∆/∆ CMPs 
compared with control cells. However, a significant increase in late apoptosis 
was detected in Vav-Atmin∆/∆ CMPs (Figure 1G) but not in other primitive 
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compartments (not shown) and this was accompanied by a ~33-fold decrease 
in Dynll1 expression (a direct transcriptional target of ATMIN7, Figure 1H). 
Because Dynll1 sequesters pro-apoptotic Bim away from mitochondria11, 
reduced Dynll1 levels in Vav-Atmin∆/∆ CMPs should free Bim to translocate to 
mitochondria, triggering higher apoptosis. Consistent with this, 
immunofluorescence revealed significant co-staining of Bim with MitoTracker 
dye in Vav-Atmin∆/∆ cells (Figure 1I-K).  
 As two major cell compartments downstream of LT-HSC were severely 
affected, we hypothesized that LT-HSC function could be compromised. 
Indeed, sub-populations upstream of CMPs, particularly LT-HSCs, consisted 
of more cells that had exited quiescence (Figures 2A and S3C), supported by 
reduced expression of Cdkn1c (p57Kip2) and Rbl2 (p130) (Figure 2B). 
Additionally, ATMIN-deficient primitive cells had a 2-3-fold reduction in the 
frequency of CAFCs and LTC-IC-derived colonies compared with control cells 
(Figure 2C-D). Importantly, the regenerative capacity of Vav-Atmin∆/∆ LT-
HSCs 16 weeks post-transplantation was reduced 16-fold compared with 
control cells, affecting all three lineages (Figures 2E and S3D) and this was 
not due to homing defects (Figure 2F). Vav-Atmin∆/∆ LT-HSCs were mostly 
unable to regenerate hematopoiesis when re-transplanted (Figure 2E), 
despite the apparent lack of oxidative stress, increased apoptosis (Figure 
S3E-F), or active DNA damage response in young Vav-Atmin∆/∆ cells at 
steady state (Figure 2G-H). These results suggest that stresses induced 
during regeneration disturbed LT-HSC function.  
Consistent with disturbed LT-HSC function, aged (55-65-week-old) 
Vav-Atmin∆/∆ mice continued to have reduced BM cellularity (Figure S3G) with 
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similar defects in aged ATMIN-deficient B cells as reported8 (data not shown) 
and a reduced CMP compartment (Figure S3H). Although the numbers of 
short-term (ST)-HSCs and multipotent progenitors (MPPs) were not altered in 
aged ATMIN-deficient mice, the proportion of these sub-populations was 
increased, perhaps due to increased cell cycling in younger but not in aged 
mice (Figures 2I-J and S3H-I). As in young mice, ATMIN-deficient primitive 
cells from aged mice had a reduced capacity to produce CAFCs and LTC-IC 
colonies (Figure 2K-L) and LT-HSCs lacking ATMIN were unable to provide 
long-term reconstitution (Figure 2M), although BM homing was unaffected 
(Figure 2N). There were no apparent signs of senescence (such as increased 
p16Ink4a and p19Arf expression) in any of the aged ATMIN-deficient primitive 
sub-populations (data not shown) and no increase in ROS production in 
ATMIN-deficient LT-HSCs was observed (Figure S3J), unlike in Atm-/- 
mice12,13. Contrary to young cells, we observed a significant increase in 
expression of DNA oxidation repair genes in aged ATMIN-deficient LT-HSCs, 
as well as an increase in pKap1, suggesting that both aging and ATMIN 
deficiency are required to stimulate this response (Figure 2O-P). 
Regeneration of PB hematopoiesis after myelo-suppressive 5-FU treatment 
was much weaker in ATMIN-deficient compared with control mice (Figure 
2Q). ATMIN-deficient LT-HSCs cycled less and showed an increased DNA 
damage response compared with control cells at day 7 post-5-FU treatment 
(Figure 2R-S). Vav-Atmin∆/∆ mice succumbed to multiple doses of 5-FU faster 
than Atminf/f mice (Figure 2T).  
 We reveal ATMIN as a novel player with multiple functions in 
hematopoiesis, that are both ATM-dependent and -independent. We have 
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uncovered an important ATM-independent function of ATMIN in the CMP 
compartment. ATMIN-deficient mice also have impaired LT-HSC function 
during regeneration and aging, most likely due to exhaustion from 
compensating for the reduced/damaged lymphoid and myeloid compartments 
over time. It would be interesting to dissect other possible roles that ATMIN 
might have in myeloid development with more specific lineage gene deletion 
approaches, as myeloid cells can differentiate without passing the CMP 
stage14-16.  
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Figure legends 
 
Figure 1. ATMIN-deficient mice have a reduced CMP compartment due to 
increased apoptosis. Black bars/symbols represent Atminf/f and white Vav-
Atmin∆/∆ unless otherwise indicated. (A) DCFDA stains for ROS detection 
showing a mild increase in the percentage of ROS-positive cells in ATMIN-
deficient CMPs (n=3/genotype). (B) Treating total BM cells with the 
antioxidants NAC or γ-GCE (not shown) was unable to rescue the myeloid 
colony formation (CFU) defect of Vav-Atmin∆/∆ cells (n=5/genotype). (C) 
Expression of key anti-oxidant genes was unchanged between ATMIN-
deficient and control CMPs. Expression values were determined by qRT-PCR 
and were relative to the mean (n=3-5/genotype). No significant increase in 
pKap1 levels (indicative of ATM activation) (D), upregulation of genes 
required for DNA oxidation repair (E), or changes in the indicated CMP 
developmental factors (F) were detected in ATMIN-deficient compared with 
control CMPs. pKap1 levels were determined by intracellular flow cytometry 
analysis (MFI ratios are shown) and qRT-PCR was used to determine the 
expression of the indicated genes (n=5-6/genotype). (G) The frequency of late 
apoptosis was significantly increased and (H) Dynll1 expression was 
drastically reduced in CMPs lacking ATMIN compared with control cells (n=4-
6/genotype). (I) Representative cell images captured by an ImageStream flow 
cytometer in green and red channels followed by their respective composite 
images, showing higher co-localization of mitochondria (red) with Bim (green) 
staining in Vav-Atmin∆/∆ CMPs. (J) Representative MitoTrackerRed-CMXRox 
and Bim similarity staining score histograms for Atminf/f (black) and Vav-
Atmin∆/∆ (open)-derived CMPs respectively. A score above value 2 (R1) 
indicates translocation of Bim into mitochondria. (K) Percentage of Bim 
translocation in CMPs (n=3/genotype). The different BM hematopoietic stem 
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and progenitor populations were defined as follows: LT-HSC ((L-S+K+ 
(Lineage-Sca-1+cKit+) CD34-/loFlt3-); ST-HSC (L-S+K+ CD34+Flt3-); MPP (L-
S+K+CD34+Flt3+); CMP (L-S-K+IL7R-CD34+FcγR−); GMP (granulocyte-
monocyte progenitor, L-S-K+IL7R-CD34+FcγR+); MEP (megakaryocytic-
erythroid progenitor; L-S-K+IL7R-CD34-FcγR-); CLP (L-S-KloIL7R+). Mean (SD) 
values are shown. *, P<0.03; ***, P<0.0003. 
 
Figure 2. Vav-Atmin∆/∆ LT-HSCs have impaired functions during 
regeneration and aging. Experiments were performed with young (A-H and 
Q-T) and aged (I-P) BM cells. Black bars/symbols and lines represent Atminf/f 
and white bars/symbols and grey lines Vav-Atmin∆/∆ unless otherwise 
indicated. (A, I) Cell cycle distribution was determined using Ki67/DAPI stains 
in BM LT-HSCs (n=4/genotype). (B, J) qRT-PCR for the expression of 
Cdkn1c and Rbl2 in LT-HSCs. Expression values are relative to the mean of 
control (n=3-5/genotype). Other cell cycle regulators were unchanged 
between ATMIN-deficient and control cells (data not shown). (C, K) To 
estimate the stem/progenitor cell capacity of the more primitive cells, the 
frequency of L-S+K+ cells to form cobblestone area-forming cells (CAFCs) was 
determined by limiting dilution 5 wks after seeding on MS5 stroma. Five week 
long-term culture-initiating cell (LTC-IC) -derived colonies were also 
determined (D, L; n=3/genotype). (E) To evaluate the regeneration capacity of 
LT-HSCs, peripheral blood (PB) chimerism was determined at different time 
points from sub-lethally irradiated NSG mice (non-obese diabetic/severe 
combined immunodeficiency disease/interleukin-2 receptor γ-chain–null; 
CD45.1 due to the mixed background) that were transplanted with 15 young 
LT-HSCs from either Atminf/f or Vav-Atmin∆/∆ mice (CD45.2). After 16 wks, 15 
LT-HSCs were sorted by flow cytometry from primary mice and re-
transplanted into separate secondary recipients and PB chimerism was 
determined at different time points. (M) PB chimerism was also determined 
from sub-lethally irradiated NSG mice transplanted with 15 aged LT-HSCs 
from either Atminf/f or Vav-Atmin∆/∆ mice. (F, N) Percentage of engrafted LT-
HSCs 16h after intravenous injection of total Atminf/f or Vav-Atmin∆/∆ BM 
mononuclear cells (n=2 independent experiments). Each symbol indicates a 
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mouse and horizontal lines represent median reconstitution levels. (G, O) 
qRT-PCR for the expression of the indicated DNA oxidation repair genes in 
LT-HSCs was also evaluated. Expression values were relative to the mean of 
each control sub-population (n=3/genotype). (H, P) pKap1 expression in LT-
HSCs was determined by intracellular flow cytometry analysis. Grey and open 
histograms represent isotype-matched control and pKap1 stains respectively 
(n=3/genotype). (Q) Hematopoietic reconstitution was monitored by serial PB 
counts in mice injected with a single dose of 5-FU. Total WBC counts are 
shown (n=5-6/genotype). Cell cycle status (R) and pKap1 expression (S) in 
ATMIN-deficient and control LT-HSCs at day 7 after a single dose of 5-FU 
administration (n=4-5/genotype). (T) Kaplan-Meier survival curve of Atminf/f 
and Vav-Atmin∆/∆ mice injected 3 times (arrows) with 5-FU (n=7-8/genotype). 
Unless stated, mean (SD) values are shown.  
*, P<0.03; **, P<0.003; ***, P<0.0003.  
 


 Supplementary Figures 
 
Figure S1. ATMIN-deficient mice are leukopenic. (A) Genotyping of Atmin 
WT, floxed and Δ alleles by PCR from tail, thymus, spleen and bone marrow 
(BM) of Atminf/f, Atminf/+ and Vav-Atmin∆/∆ mice. (B) Representative western 
blot using Atminf/f and Vav-Atmin∆/∆ bone marrow lysates. Adult Vav-Atmin∆/∆ 
mice are leukopenic but not anemic as shown by (C) the reduced absolute 
peripheral blood leukocyte (CD45+), B cell, T cell, granulocyte and (D) red 
blood cell counts respectively (n=6/genotype; 8-12-wks old). Mean (SD) 
values are shown. *, P<0.03; ***, P<0.0003. 
 
Figure S2. ATMIN-deficient mice have B cell lymphopenia. (A) Analysis of 
total B cell (B220+) numbers in the spleens of Vav-Atmin∆/∆ mice and Atminf/f 
litter-mates (8-12-wk-old; n=5/genotype) showing a ~75% reduction in total B 
cell numbers in Vav-Atmin∆/∆ mice compared with control mice. This was 
accompanied by a significant reduction in (B) the frequency of immature and 
re-circulating B cells (n=5/genotype) and (C) loss of germinal centre (GC) and 
red pulp regions (RP; representative H&E stainings of spleens are shown). 
(D) No increase in intracellular reactive oxygen species (ROS) was detected 
in the different Vav-Atmin∆/∆ B cell sub-populations (n=3/genotype). (E) A 
significant 2-fold increase in early apoptosis was observed in all the different 
B cell sub-sets analyzed (each dot represents a mouse). (F) Expression of 
Dynll1 (a direct ATMIN transcriptional target6 responsible for sequestering the 
pro-apoptotic protein Bim12) was reduced in Vav-Atmin∆/∆ cells. Expression 
values were determined by qRT-PCR and were relative to the mean of each 
control population (n=3-5/genotype). (G, H) Atmin-deleted B cells show an 
increase in pKap1 (an ATM substrate) and γH2AX compared with control B 
cells. Expressions were determined by intracellular flow cytometry analysis 
and mean fluorescence intensity (MFI) ratios are shown. (I) Total B cell 
numbers are significantly reduced in the BM of Vav-Atmin∆/∆ mice compared 
with Atminf/f littermates (from two tibiae, two femurs and two iliac crests; n=6-
7/genotype). Pre-B cell counts are reduced by 50%. (J) No accumulation of 
other primitive B cell sub-sets was observed in the absence of ATMIN. (K) BM 
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cells were unable to efficiently generate pre-B cell colonies in vitro 
(n=3/genotype; in triplicate each). Mean (SD) values are shown.  
*, P<0.03; **, P<0.003; ***, P<0.0003. 
 
Figure S3. Vav-Atmin∆/∆ LT-HSCs have impaired functions during aging 
and regeneration after transplantation or 5-FU treatment. (A, G) Total 
cellularity and absolute numbers of the indicated sub-populations were 
determined in the BM of Atminf/f and Vav-Atmin∆/∆ mice (from two tibiae, two 
femurs and two iliac crests; n=5-6/genotype). (B, H) Frequencies of the 
different primitive BM stem/progenitor sub-populations (n=6-8/genotype) were 
also analyzed. Horizontal bars indicate the mean. (C, I) Cell cycle distribution 
was determined using Ki67/DAPI stains in the indicated BM stem/progenitor 
sub-populations (n=4/genotype). (D) Contribution of the transplanted primary 
LT-HSCs (as shown in Figure 2E) to the B, T and granulocyte cell lineages. 
Each symbol indicates a mouse and horizontal lines represent median 
reconstitution levels. (E, J) As Atm-/- LT-HSCs have 10-fold elevated ROS 
compared to WT cells10, we investigated ROS production in Atminf/f or Vav-
Atmin∆/∆ LT-HSCs. DCFDA stains for ROS detection are shown. Values 
indicate the percentage of ROS-positive cells (n=3/genotype). (F) Frequency 
of late apoptosis in young LT-HSCs (n=4-6/genotype). Mean (SD) values are 
shown. *, P<0.03; **, P<0.003. 
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Supplementary Materials and Methods 
Mice 
NSG mice: Nonobese diabetic/severe combined immunodeficiency 
disease/interleukin-2 receptor γ-chain–null (NOD/SCID IL2Rγnull; NSG) mice 
were originally obtained from Dr Leonard Schultz (Jackson Laboratory) and 
bred in the London Research Institute Biological Resources Unit. Mice were 
kept in micro-isolators and fed sterile food and acidified water. All 
experimental procedures were approved by London Research Institute ethics 
committees and conform to the UK Home Office regulations. 
 
Bone marrow transplantation and 5-FU treatment 
 NSG mice aged 8 to 12 weeks were irradiated at 3.75 Gy (137Cs 
source) up to 24 hours before tail vein injection of flow cytometry-purified 
primary cell populations. For secondary transplants, two NSG mice that 
received LT-HSCs from either Atminf/f or Vav-Atmin∆/∆ mice were randomly 
pooled and sorted again for LT-HSCs and injected into two sub-lethally 
irradiated NSG mice. Atminf/f and Vav-Atmin∆/∆ mice aged 8 to 12 weeks 
received a single dose of 5-FU (150 mg/Kg body weight) and were analyzed 
for cell cycle distribution, pKap1 expression and different white blood cell 
counts. Survival of mice was determined after 3 injections of 5-FU. For 
homing experiments, Atminf/f or Vav-Atmin∆/∆ mice were sacrificed and single 
cell suspensions of the BM were used for transplantation. BM mononuclear 
cells equivalent to 1000 LT-HSCs were injected through the tail vein into sub-
lethally irradiated NSG recipient mice. Sixteen hours after transplant, the 
recipient mice were sacrificed and the BM cells of the lower limbs and pelvis 
were harvested and homing of immunophenotypically identified LT-HSC was 
performed as described. 
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Hematopoietic analyses 
 Single-cell suspensions were first obtained from different hematopoietic 
tissues, then red blood cells were lysed and samples stained for 30 min. at 
4°C with the indicated antibodies in PBS supplemented with 2% FCS 
(PBS/2%). DAPI was added to exclude dead cells in the flow cytometry 
analysis. For complete blood counts, peripheral blood was collected from the 
tail vein into tubes containing K2EDTA. Twenty-five µl of blood was stained for 
different leukocyte antigens as described then without washing diluted to 1 ml 
and analysed in a MACSQuant analyser (Miltenyi Biotec). For red blood cell 
counts, blood was diluted 1:1000 and red cells were counted in a 
hemocytometer. The following antibodies (from BD Bioscience and 
eBioscience) were used: Lineage cocktail, CD45.1 (A20), CD45.2 (104), B220 
(RA3-6B2), Ly-6G (Gr1; RB6-8C5), CD3 (17A2), Sca-1 (D7), CD117 (c-Kit; 
2B8), CD34 (RAM34), CD16/32 (93), CD43 (S7), IgM (II/41), CD135 (Flt3; 
A2F10), CD127 (IL7Rα; A7R34) and AnnexinV. 
 
Analysis of intracellular ROS and mitochondria.  
 Cells were incubated with the ROS detection agent DCFDA (carboxy-
H2DFFDA C13293; Life Technologies) at 5 µM or MitoTrackerRed-CMXRos 
(M7512; Life Technologies) at 12.5 nM and incubated at 37°C for 30 min. 
After this period cells were washed with PBS/2% FBS containing trypan blue 
to quench nonspecific staining. 
 
Gene Expression Analysis 
 RNA was extracted using the RNeasy Micro Kit (Qiagen, Inc.) and 
treated with DNase.  Reverse transcription was performed using the 
SensiScript Kit (Qiagen) according to the manufacturer's instructions. For 
quantitative real-time polymerase chain reaction (qRT-PCR), SybrGreen 
master mix reagent (Applied BioSystems) was used and the amplification was 
done using the ABI Prism 7700 sequence detection system (Applied 
BioSystems). To avoid possible amplification of contaminating DNA and 
unprocessed mRNA, where possible, primers were designed to anneal the 
end parts of two exons. The specificity of the PCR products was verified by 
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running a 2% agarose gel, in addition to using the dissociation curve software 
from the qRT-PCR system.  Primers used are listed in Table S1. 
 
CAFC and LTC-IC-CFC assays 
 Briefly, FACS purified L-S+K+ cells were co-cultured as bulk or using a 
limiting dilution analysis (LDA) both on 80% confluent monolayer of MS5 
stromal cells with M5300 media (Stemcell Technologies) supplemented with 
Pen/Strep and hydrocortisone at 10-6 M. Cells were cultured at 37°C in 5% 
CO2 -humidified incubators for 5 wks with weekly half-media change. For the 
LDA CAFC assay cells were plated in 96-well microplates and wells were 
scored for the presence of CAFCs. To determine the frequency, LDA was 
calculated using the extreme limiting dilution analysis from WEHI (Walter and 
Eliza Hall Institute) bioinformatics website according to the Poisson statistics 
and method of maximum likelihood. For LTC-IC-derived colonies, cells were 
recovered after 5 wks of co-culture and plated on standard methylcellulose 
colony assay media as described below.  
 
Colony assays 
 Standard methylcellulose colony assay media, MethoCult® GF M3534 
was used according to the manufacturer’s instructions. NAC (N-acetyl 
cysteine; Sigma) or γ-GCE (glutathione monoethyl ester; Calbiochem) was 
added to the methylcellulose at 100 µM or 2 mM respectively when cells were 
seeded and then at day 5. Colonies were scored at day 10.  
 
Immunohistochemistry 
 Tissue was fixed overnight in 10% neutral buffered formalin, briefly 
washed with PBS and transferred into 70% ethanol, processed and 
embedded into paraffin. Sections were cut at 4 µm for H&E staining. 
 
Western blotting  
 Cells were extracted in RIPA lysis buffer (NEB) supplemented with 
protease inhibitors (Sigma). Western blots were performed using standard 
procedures. Protein samples were separated by SDS–PAGE, and 
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subsequently transferred onto nitrocellulose membranes. All primary 
antibodies were used at 1:1000 dilution and secondary antibodies at 1:2000. 
The following antibodies were used: p-S824-Kap1 (Bethyl Laboratories, Inc); 
ATMIN, (Millipore); β-actin (Sigma); α−tubulin (Abcam); HRP-conjugated goat 
anti-mouse/rabbit IgG (Sigma). 
 
ImageStream analysis  
 Cells were stained first for extracellular antigens followed by 
mitochondria staining. Cells were then fixed, permeabilized and stained for 
Bim as described above. Samples were analyzed on an ASSIST calibrated 
Dual Camera, 12 Channel ImagestreamX Mark II Imaging Flow Cytometer 
(Amnis, Merck Millipore) using INSPIRE software (Amnis, Merck 
Millipore). Images were collected using a 60x objective lens and sample data 
were acquired on a low speed and high sensitivity setting. Fluorescence was 
measured from 405nm, 488nm and 642nm lasers. Laser powers were set to 
30mW, 50mW and 30mW respectively. A dot-plot of area vs aspect ratio for 
Brightfield Ch01 was gated to exclude debris during data acquisition. Single 
stained cells were measured and a compensation matrix created; the 
acquired data were compensated and analysed using IDEAS software 
(Amnis, Merck Millipore). Gates were set to include single, focused cells and 
then gated for cells which were dual stained with MitoTrackerRed-CMXRos 
(Ch04) and Bim AlexaFluor 488 (Ch02). The “similarity” feature was used to 
assess the colocalization of the MitotrackerRed-CMXRos and Bim on selected 
cell populations. The following modified feature and mask was used to 
measure and define the region where the colocalization of the 2 dyes occurs: 
Similarity Threshold: Similarity Threshold ((Object (M04, Ch04 MitoCMXRos, 
Tight), Ch04 MitoCMXRos: 60))_Ch02 Bim AF488_Ch04 MitoCMXRos. Cells 
which scored more than 2 on this feature were assessed to have high 
Bim/mitochondria colocalization.  
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Statistical analysis 
 T-tests were used for most analyses. Statistical analysis of the 
engraftment data was performed using the Mann-Whitney test. The P value 
for the Kaplan-Meier survival curve was calculated using the Mantel-Cox test. 
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Table S1. List of primers used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



